POLYRIZON
Polyrizon is a domain name services firm expertise in domain consulting and boutique domain brokerage services.
POLYRIZON
Social Links:
Industry:
Biotechnology
Address:
Ra'anana, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.polyrizon-biotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Maps LetsEncrypt SSL By Default Font Awesome
Similar Organizations
albero
albero is a company that expertise in domain registration, web construction and CMS services.
Domain Cocoon
Domain Cocoon helps to protect and grow domain names and provides custom registrar solutions, consultation and management services.
Yash Infosolutions
Yash Infosolutions is an IT company that provides domain registration, web design, security management, consultation, and cloud services.
Current Employees Featured
Official Site Inspections
http://www.polyrizon-biotech.com
- Host name: 699050.cloudwaysapps.com
- IP address: 46.101.45.46
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Polyrizon"
PLRZ - Overview
Polyrizon Ltd. Company Overview We are a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, โฆSee details»
PLRZ - Governance - investor.polyrizon-biotech.com
Audit Committee Compensation Committee Nominating and Corporate Governance Committee Mr. Asaf Itzhaik Yehonatan Zalman VinokurSee details»
PLRZ - Management - investor.polyrizon-biotech.com
Dr. Tidhar Turgeman has served as our Chief R&D Officer since December 2020. Prior to that, Mr. Turgeman served as an Innovative drug delivery technologies products development โฆSee details»
Polyrizon Company Profile - Office Locations, Competitors, โฆ
Polyrizon has 1 employees at their 1 location. See insights on Polyrizon including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. ... Polyrizon is a โฆSee details»
Polyrizon Enters into GMP Manufacturing Agreement for CTM โฆ
Raanana, Israel, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of โฆSee details»
Polyrizon - CAPTURE & CONTAIN
The Capture and Contain Platform (C&Cโข) is based on natural 3-D polymeric network tailored to optimally adhere to the nasal mucosal surface. The polymeric network creates a physical barrier that Captures and Contains biological โฆSee details»
Polyrizon - Expanding horizons of intranasal care - polyrizon โฆ
Polyrizon is a biotech company, focused on the development and commercialization of innovative intranasal products based on the Companyโs technology platforms.See details»
Polyrizon Enters into GMP Manufacturing Agreement for CTM
Dec 3, 2024 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin โฆSee details»
Polyrizon Ltd. Company Research Report - askcyborg.com
Polyrizon Ltd. is a trailblazing company at the forefront of biotechnology, specializing in the development of innovative solutions to protect againstSee details»
PLRZ - Board of Directors - investor.polyrizon-biotech.com
Prior to that, between 2021 to 2024, Mr. Srugo was a Senior Financial Advisor at Somekh Chaikin, a member firm of KPMG, where he led teams in financial due diligence and โฆSee details»
PLRZ Stock Price Quote - Morningstar
Dec 5, 2024 Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross โฆSee details»
Polyrizon Teams Up With Eurofins To Secure Clinical Trial ... - Nasdaq
Dec 2, 2024 (RTTNews) - Polyrizon Ltd. (PLRZ), a biotech company, announced today that it has entered into a manufacturing agreement with Eurofins Contract Development & โฆSee details»
Polyrizon Enters into GMP Manufacturing Agreement for CTM โฆ
Dec 2, 2024 Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the โฆSee details»
Trap & Target - Polyrizon-Biotech
Providing new horizon for Intranasal drugs delivery. The T&T platform delivery technology is designed to allow a long residence time and an intimate contact with the mucosal tissue for a โฆSee details»
Polyrizon pays $3M for license to SciSparc's CB2R agonist - Fierce โฆ
Aug 19, 2024 Israeli biotech SciSparc has sold the license for its cannabinoid receptor type 2 (CB2R) agonist to its partner Polyrizon to further develop as a pain therapy.. The agreement โฆSee details»
PLRZ - Stock Info - investor.polyrizon-biotech.com
Nov 19, 2024 Date Price Open Prev CloseSee details»
Polyrizon Stock Price | PLRZ Stock Quote, News, and History
Nov 3, 2024 On Tuesday morning 12/10/2024 the Polyrizon Ltd Registered Shs share started trading at the price of $1.07. Compared to the closing price on Monday 12/09/2024 on BTT of โฆSee details»
Polyrizon (PLRZ) Stock Price, News & Analysis - MarketBeat
3 days ago Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. โฆSee details»
Polyrizon Enters into GMP Manufacturing Agreement for CTM
Dec 2, 2024 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin โฆSee details»
Polyrizon - Press release - polyrizon-biotech.com
Press Release July 2022 Polyrizon Signed an Agreement with Nurexone for Intranasal Administration of Cutting - Edge Therapy for Spinal Cord Injuries Link July 2022 May 2022 โฆSee details»